OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The evolving biology of Mycobacterium tuberculosis drug resistance
R. Mark Jones, Kristin N. Adams, Hassan E. Eldesouky, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 21

Showing 21 citing articles:

Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement
José Domínguez, Martin J. Boeree, Emmanuelle Cambau, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 4, pp. e122-e137
Closed Access | Times Cited: 56

Evaluation of the Anti-Mycobacterial and Anti-Inflammatory Activities of the New Cardiotonic Steroid γ-Benzylidene Digoxin-15 in Macrophage Models of Infection
Daniel Magalhães, Maria Gabriella S. Sidrônio, N.F.S. Nogueira, et al.
Microorganisms (2025) Vol. 13, Iss. 2, pp. 269-269
Open Access | Times Cited: 2

Tackling Drug-Resistant Tuberculosis: New Challenges from the Old Pathogen Mycobacterium tuberculosis
Giuseppe Mancuso, Angelina Midiri, Silvia De Gaetano, et al.
Microorganisms (2023) Vol. 11, Iss. 9, pp. 2277-2277
Open Access | Times Cited: 29

The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance
M. Alexandra Lake, Kristin N. Adams, Feilin Nie, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 7
Open Access | Times Cited: 18

Computer-Aided Drug Design Approaches for the Identification of Potent Inhibitors Targeting Elongation Factor G of Mycobacterium tuberculosis
Mushtaq Ahmad Wani, A. Banerjee, Prabha Garg
Journal of Molecular Graphics and Modelling (2025) Vol. 136, pp. 108954-108954
Closed Access

State of the Art and Emerging Technologies in Vaccine Design for Respiratory Pathogens
Matteo Ridelfi, Giulio Pierleoni, V. Fonseca, et al.
Seminars in Respiratory and Critical Care Medicine (2025)
Closed Access

Decoding the Role of Antimicrobial Peptides in the Fight against Mycobacterium tuberculosis
Sapna Saini, Soma Pal, Rashmi Sharma
ACS Infectious Diseases (2025)
Closed Access

Tools to develop antibiotic combinations that target drug tolerance in Mycobacterium tuberculosis
Talia Greenstein, Bree B. Aldridge
Frontiers in Cellular and Infection Microbiology (2023) Vol. 12
Open Access | Times Cited: 8

Persistence and evidence for accelerated biodegradation of streptomycin in agricultural soils
Megan Demars, Tim McDowell, Justin B. Renaud, et al.
The Science of The Total Environment (2024) Vol. 929, pp. 172502-172502
Closed Access | Times Cited: 2

Prediction of Mycobacterium tuberculosis cell wall permeability using machine learning methods
A. Banerjee, Anju Sharma, Pradnya Kamble, et al.
Molecular Diversity (2024) Vol. 28, Iss. 4, pp. 2317-2329
Closed Access | Times Cited: 1

Navigating the Challenge of Tuberculosis Drug Resistance: Unveiling Intrinsic and Acquired Pathways to Overcome the Threat
Hafiz Muhammad Aslam, Muhammad Umar Sharif, Amna Uroos, et al.
Journal of Advances in Microbiology (2024) Vol. 24, Iss. 6, pp. 12-29
Open Access

Cystatin F Depletion in Mycobacterium tuberculosis-Infected Macrophages Improves Cathepsin C/Granzyme B-Driven Cytotoxic Effects on HIV-Infected Cells during Coinfection
Manoj Mandal, David Pires, Marta Calado, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8141-8141
Open Access

Decoding drug resistance in mycobacterium tuberculosis complex: genetic insights and future challenges
Amey Deshpande, Rupali Likhar, Tabassum Khan, et al.
Expert Review of Anti-infective Therapy (2024) Vol. 22, Iss. 7, pp. 511-527
Closed Access

Netupitant Exhibits Potent Activity on Mycobacterium tuberculosis Persisters
Hassan E. Eldesouky, Richard M. Jones, Natalie S. Gleason, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Antibiotic Resistance in Mycobacterium Tuberculosis and Non-Tuberculous Mycobacteria
Ronald Wamalwa, Bernard Guyah, Nathan Shaviya
African Journal of Empirical Research (2024) Vol. 5, Iss. 4, pp. 1001-1010
Open Access

Genotypes and drug resistance pattern of Mycobacterium tuberculosis complex among clinically diagnosed pulmonary tuberculosis patients
Alem Alemayehu, Liya Wassie, Dawit Hailu Alemayehu, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access

Tuberculosis farmacorresistente: Mecanismos moleculares de Mycobacterium tuberculosis
Anaximandro Gómez-Velasco, René Armando Rodríguez-Suárez, Pilar Granja-Pérez, et al.
Investigación y Ciencia de la Universidad Autónoma de Aguascalientes (2024), Iss. 91
Open Access

The Mycobacterium bovis BCG GroEL1 Contributes to Isoniazid Tolerance in a Dormant-Like State Model
Sheng Zeng, Dong Yang, Céline Rens, et al.
Microorganisms (2023) Vol. 11, Iss. 2, pp. 286-286
Open Access | Times Cited: 1

Persistence and Evidence for Accelerated Biodegradation of Streptomycin in Agricultural Soils
Megan Demars, Tim McDowell, Justin B. Renaud, et al.
(2023)
Closed Access | Times Cited: 1

Page 1

Scroll to top